-
FDA rejects IV tramadol as opioid alternative for second time
by Robert Stott on June 14, 2021 at 7:54 pm
Avenue Therapeutics announced the FDA has issued a second complete response letter regarding the new drug application for intravenous […]
-
Refractory Lyme arthritis may be driven by 'maladaptive immune response'
by Rob Volansky on June 14, 2021 at 5:00 pm
A maladaptive immune response may be prompting arthritic complications in patients with persistent and drug-refractory Lyme disease, […]
-
Immunocompromised? What to Do If You Get Pushback for Wearing a Mask in Public
by Kelsey Kloss on June 14, 2021 at 1:16 pm
Although the U.S. Centers for Disease Control and Prevention (CDC) announced that fully vaccinated people no longer have to wear masks in […]
-
AMA survey: 96% of physicians fully vaccinated against COVID-19
on June 11, 2021 at 7:30 pm
Most practicing physicians in the United States who were surveyed reported being fully vaccinated against COVID-19, with no significant […]
-
Tele-rheumatology debate pits efficient care against reduced doctor-patient relationship
by Rob Volansky on June 11, 2021 at 7:16 pm
While COVID-19 ushered in what many believe to be a long overdue increase in telehealth in rheumatology, whether its benefits justify the […]
-
Despite risks, opioid users more likely to receive sedating medications
by Janel Miller on June 11, 2021 at 6:50 pm
Individuals who used or abused opioids were significantly more likely to receive sedating medications, including benzodiazepines, than […]
-
KEEPsAKE 2: Risankizumab improves signs, symptoms in refractory PsA
by Jason Laday on June 11, 2021 at 3:23 pm
Risankizumab is linked to significantly greater improvements in psoriatic arthritis signs and symptoms than placebo in patients with an […]
-
CreakyJoints Reports that Women Endure Symptoms of Inflammatory Arthritis Despite Availability of Medications Proven Safe for Pregnant and Lactating Mothers
by CreakyStaff on June 11, 2021 at 3:09 pm
The post CreakyJoints Reports that Women Endure Symptoms of Inflammatory Arthritis Despite Availability of Medications Proven Safe for […]
-
What Immunocompromised People Should Know About COVID-19 Vaccine Boosters (So Far)
by Kelsey Kloss on June 11, 2021 at 11:52 am
People who are immunocompromised may be interested in COVID-19 vaccine boosters, as they may be less protected against the coronavirus than […]
-
SELECT-PsA 2: Upadacitinib maintains efficacy against PsA at 1 year
by Jason Laday on June 11, 2021 at 9:30 am
Upadacitinib maintains its efficacy over 56 weeks in patients with psoriatic arthritis who had a prior inadequate response to at least one […]
-
ACR RA guidelines: 'Maximize' methotrexate use prior to DMARDs, avoid glucocorticoids
by Jason Laday on June 10, 2021 at 6:36 pm
The American College of Rheumatology has released its updated treatment guidelines for rheumatoid arthritis, with a strong emphasis on the […]
-
Disease Flares from the COVID-19 Vaccine are ‘Rare and Mild’ Among Rheumatic Disease Patients
by Kelsey Kloss on June 10, 2021 at 5:29 pm
The news is reassuring for arthritis and rheumatic disease patients who have been concerned about the potential risk of post-vaccine […]
-
COVID-19-related disruptions in rheumatology care only partly offset by telehealth
by Jason Laday on June 10, 2021 at 3:05 pm
Rheumatology follow-up visit cancellations climbed to 60% during the height of the COVID-19 pandemic, and were more common for older, […]
-
The Risk of Dementia and Heart Failure Among Rheumatoid Arthritis Patients Is Declining
by Barbara Brody on June 10, 2021 at 1:05 pm
Recent advances in rheumatoid arthritis treatment have made it possible to slow the disease’s progression and, in turn, reduce the risk […]
-
Patients with autoimmune disease rated care from APPs similarly to that of rheumatologists
by Jason Laday on June 10, 2021 at 9:30 am
Patients who received rheumatology care from nurse practitioners or physician assistants rated their overall experience similarly to those […]
Categories What's New
March 24, 2020